Breaking News Instant updates and real-time market news.

2022-07-06 10:03:09 RGF Real Good Food $6.54 / + (+0.00%) 10:03 07/06/22 07/06 10:03 07/06/22 10:03	Real Good Food launches Real Good Foods Perks Program The Real Good Food Company announcedthe launch of their Real Good Foods Perks Program on the Stockperks app. Real Goods Foods shareholders who leverage the Stockperks app can redeem perks based upon four levels of shareholding. Perks include digital gift cards for Realgoodfoods.com, Visa Gift Cards to purchase Real Good Foods products at major retailers such as Wal-Mart, Costco, Target or Kroger, a selection of merchandise in the Real Good Foods shareholder store, and for the largest shareholders, a special "Real VIP Perk." The Real VIP Perk includes priority access to taste new Real Good Foods innovations, complimentary fresh-to-your-door monthly delivery of the company's amazing products, company merchandise, gift cards and more. Please visit the Stockperks app for more details on how to claim the Real Good perks.	05 Nov

2022-07-06 10:03:09

RGF

Real Good Food

$6.54 / + (+0.00%)

10:03

07/06/22

07/06

10:03

07/06/22

10:03

Real Good Food launches Real Good Foods Perks Program

The Real Good Food Company announcedthe launch of their Real Good Foods Perks Program on the Stockperks app. Real Goods Foods shareholders who leverage the Stockperks app can redeem perks based upon four levels of shareholding. Perks include digital gift cards for Realgoodfoods.com, Visa Gift Cards to purchase Real Good Foods products at major retailers such as Wal-Mart, Costco, Target or Kroger, a selection of merchandise in the Real Good Foods shareholder store, and for the largest shareholders, a special "Real VIP Perk." The Real VIP Perk includes priority access to taste new Real Good Foods innovations, complimentary fresh-to-your-door monthly delivery of the company's amazing products, company merchandise, gift cards and more. Please visit the Stockperks app for more details on how to claim the Real Good perks.

05
Nov

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	AirSculpt Technologies announces special cash dividend of 41c per share » 06:08 08/12/22 08/12 06:08 08/12/22 06:08 AIRS AirSculpt Technologies $8.85 / -0.45 (-4.84%) On August 10, the Board… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Syndicate On The Fly Events AIRS AirSculpt Technologies $8.85 / -0.45 (-4.84%) 06/16/22 Morgan Stanley AirSculpt downgraded to Equal Weight from Overweight at Morgan Stanley 02/09/22 Piper Sandler Piper Sandler bullish into AirSculpt Technologies Q4 results 01/25/22 Piper Sandler AirSculpt Technologies transferred with Overweight at Piper Sandler 12/21/21 Piper Sandler AirSculpt should could double from current levels, says Piper Sandler AIRS AirSculpt Technologies $8.85 / -0.45 (-4.84%) 06:05 Today AirSculpt Technologies backs FY22 revenue view $175M-$179M, consensus $177.42M 06:04 Today AirSculpt Technologies reports Q2 EPS 1c, consensus 0c 05/13/22 AirSculpt Technologies raises 2022 revenue view to $175M-$179M from $172M-$176M 05/13/22 AirSculpt Technologies reports Q1 EPS (1c), consensus 4c 29 Oct AIRS AirSculpt Technologies $8.85 / -0.45 (-4.84%) 06/16/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/11/22 What You Missed On Wall Street On Friday 03/11/22 What You Missed On Wall Street This Morning 03/11/22 Fly Intel: Pre-market Movers 08:30 Today AirSculpt Technologies - AIRS 09/12/22 AirSculpt Technologies
Downgrade	4D Molecular downgraded to Market Perform from Outperform at SVB Securities » 06:07 08/12/22 08/12 06:07 08/12/22 06:07 FDMT 4D Molecular $10.37 / -0.27 (-2.54%) SVB Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events FDMT 4D Molecular $10.37 / -0.27 (-2.54%) 04/04/22 4D Molecular doses first patient in 4D-710 trial FDMT 4D Molecular $10.37 / -0.27 (-2.54%) 06/22/22 Jefferies 4D Molecular initiated with a Buy at Jefferies 06/13/22 Wedbush Sangamo assumed with a Neutral, $5 price target at Wedbush 01/04/22 SVB Leerink SVB Leerink bullish on 4D Molecular, initiates with an Outperform 01/04/22 SVB Leerink 4D Molecular initiated with an Outperform at SVB Leerink FDMT 4D Molecular $10.37 / -0.27 (-2.54%) 08/11/22 4D Molecular reports Q2 EPS (87c), consensus (85c) 05/12/22 4D Molecular reports Q1 EPS (82c), consensus (81c) 03/28/22 4D Molecular reports FY21 EPS ($2.57), consensus ($2.55) 29 Oct FDMT 4D Molecular $10.37 / -0.27 (-2.54%) 06/22/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 10/03/22 6th Annual Genetic Medicines Conference
Downgrade	Cellebrite downgraded to Market Perform from Outperform at William Blair » 06:06 08/12/22 08/12 06:06 08/12/22 06:06 CLBT Cellebrite $5.28 / -0.4 (-7.04%) William Blair analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly CLBT Cellebrite $5.28 / -0.4 (-7.04%) 07/05/22 Cellebrite and Chainalysis launch partnership 06/30/22 Cellebrite announces availability of Cellebrite Physcial Analyzer Ultra Series 05/05/22 Cellebrite announces upcoming release of Cellebrite Premium 04/06/22 Cellebrite announces national police force of EMEA expanded partnership CLBT Cellebrite $5.28 / -0.4 (-7.04%) 05/16/22 Cowen Cellebrite price target lowered to $13 from $17 at Cowen 05/13/22 Deutsche Bank Cellebrite price target lowered to $10 from $11 at Deutsche Bank 02/24/22 JPMorgan Cellebrite initiated with an Overweight at JPMorgan 02/17/22 Cowen Cellebrite price target lowered to $17 from $20 at Cowen CLBT Cellebrite $5.28 / -0.4 (-7.04%) 08/11/22 Cellebrite reports Q2 adjusted EPS 0c, consensus 3c 08/11/22 Cellebrite lowers FY22 revenue to $270M-$285M from $285M-$300M 05/12/22 Cellebrite sees FY22 revenue $285M-$300M, consensus $292.06M 05/12/22 Cellebrite reports Q1 adjusted EPS 1c, consensus 2c CLBT Cellebrite $5.28 / -0.4 (-7.04%) 02/24/22 What You Missed On Wall Street On Thursday 02/24/22 What You Missed On Wall Street This Morning 02/24/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Downgrade	Ryan Specialty Group downgraded to Sector Perform from Outperform at RBC Capital » 06:05 08/12/22 08/12 06:05 08/12/22 06:05 RYAN Ryan Specialty Group $45.32 / +0.12 (+0.27%) RBC Capital analyst Mark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events RYAN Ryan Specialty Group $45.32 / +0.12 (+0.27%) 08/11/22 Ryan Specialty Group sees FY22 organic revenue growth 16.5%-18% RYAN Ryan Specialty Group $45.32 / +0.12 (+0.27%) 07/12/22 Goldman Sachs Ryan Specialty Group assumed with a Buy at Goldman Sachs 03/31/22 William Blair Ryan Specialty can be 'rare' insurance growth stock, says William Blair 01/06/22 JPMorgan Ryan Specialty Group price target raised to $34 from $33 at JPMorgan 01/06/22 Barclays Ryan Specialty Group price target raised to $44 from $43 at Barclays RYAN Ryan Specialty Group $45.32 / +0.12 (+0.27%) 08/11/22 Ryan Specialty Group reports Q2 adjusted EPS 39c, consensus 35c 05/12/22 Ryan Specialty raises FY22 revenue growth view to 13.5%-15.5% from 13%-15% 05/12/22 Ryan Specialty reports Q1 adjusted EPS 24c, consensus 22c 03/15/22 Ryan Specialty Group sees FY22 revenue growth 13%-15%, consensus $1.69B 08/24/22 Ryan Specialty Group 08/25/22 Ryan Specialty Group
Hot Stocks	Sinopec to delist shares from NYSE » 06:05 08/12/22 08/12 06:05 08/12/22 06:05 SNP Sinopec $47.17 / +0.35 (+0.75%) Sinopec announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SNP Sinopec $47.17 / +0.35 (+0.75%) 06/19/22 Goldman Sachs Sinopec downgraded to Sell from Neutral at Goldman Sachs 05/23/22 Citi Sinopec downgraded to Sell from Buy at Citi
Earnings	AirSculpt Technologies backs FY22 revenue view $175M-$179M, consensus $177.42M » 06:05 08/12/22 08/12 06:05 08/12/22 06:05 AIRS AirSculpt Technologies $8.85 / -0.45 (-4.84%) Backs FY22 adjusted… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Syndicate On The Fly Events AIRS AirSculpt Technologies $8.85 / -0.45 (-4.84%) 06/16/22 Morgan Stanley AirSculpt downgraded to Equal Weight from Overweight at Morgan Stanley 02/09/22 Piper Sandler Piper Sandler bullish into AirSculpt Technologies Q4 results 01/25/22 Piper Sandler AirSculpt Technologies transferred with Overweight at Piper Sandler 12/21/21 Piper Sandler AirSculpt should could double from current levels, says Piper Sandler AIRS AirSculpt Technologies $8.85 / -0.45 (-4.84%) 06:04 Today AirSculpt Technologies reports Q2 EPS 1c, consensus 0c 05/13/22 AirSculpt Technologies raises 2022 revenue view to $175M-$179M from $172M-$176M 05/13/22 AirSculpt Technologies reports Q1 EPS (1c), consensus 4c 03/11/22 AirSculpt Technologies sees FY22 revenue $172M-$176M, consensus $171.04M 29 Oct AIRS AirSculpt Technologies $8.85 / -0.45 (-4.84%) 06/16/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/11/22 What You Missed On Wall Street On Friday 03/11/22 What You Missed On Wall Street This Morning 03/11/22 Fly Intel: Pre-market Movers 08:30 Today AirSculpt Technologies - AIRS 09/12/22 AirSculpt Technologies
Downgrade	CS Disco downgraded to Hold from Buy at Canaccord » 06:05 08/12/22 08/12 06:05 08/12/22 06:05 LAW CS Disco $28.96 / +0.39 (+1.37%) Canaccord analyst David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly LAW CS Disco $28.96 / +0.39 (+1.37%) 06/06/22 DISCO appoints Tom Furr as CMO 06/01/22 CS Disco falls -10.8% 04/28/22 DISCO appoints Jignasha Amin Grooms as CHRO LAW CS Disco $28.96 / +0.39 (+1.37%) 05:40 Today Cowen Cowen cuts CS Disco to Market Perform as momentum hits 'big snag' 05:35 Today Cowen CS Disco downgraded to Market Perform from Outperform at Cowen 05:22 Today Jefferies CS Disco downgraded to Hold from Buy at Jefferies 05/23/22 Jefferies CS Disco price target lowered to $35 from $40 at Jefferies LAW CS Disco $28.96 / +0.39 (+1.37%) 08/11/22 CS Disco cuts FY22 revenue view to $132M-$136M from $149M-$153M 08/11/22 CS Disco sees Q3 revenue $32M-$34M, consensus $38.29M 08/11/22 CS Disco reports Q2 adjusted (23c), consensus (27c) 05/12/22 CS Disco sees Q2 revenue $32M-$34M, consensus $34.02M 15 Sep LAW CS Disco $28.96 / +0.39 (+1.37%) 08/11/22 Fly Intel: After-Hours Movers 05/12/22 Fly Intel: After-Hours Movers
Earnings	AirSculpt Technologies reports Q2 EPS 1c, consensus 0c » 06:04 08/12/22 08/12 06:04 08/12/22 06:04 AIRS AirSculpt Technologies $8.85 / -0.45 (-4.84%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Syndicate On The Fly Events AIRS AirSculpt Technologies $8.85 / -0.45 (-4.84%) 06/16/22 Morgan Stanley AirSculpt downgraded to Equal Weight from Overweight at Morgan Stanley 02/09/22 Piper Sandler Piper Sandler bullish into AirSculpt Technologies Q4 results 01/25/22 Piper Sandler AirSculpt Technologies transferred with Overweight at Piper Sandler 12/21/21 Piper Sandler AirSculpt should could double from current levels, says Piper Sandler AIRS AirSculpt Technologies $8.85 / -0.45 (-4.84%) 05/13/22 AirSculpt Technologies raises 2022 revenue view to $175M-$179M from $172M-$176M 05/13/22 AirSculpt Technologies reports Q1 EPS (1c), consensus 4c 03/11/22 AirSculpt Technologies sees FY22 revenue $172M-$176M, consensus $171.04M 03/11/22 AirSculpt Technologies reports Q4 revenue $37.6M, consensus $34.47M 29 Oct AIRS AirSculpt Technologies $8.85 / -0.45 (-4.84%) 06/16/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/11/22 What You Missed On Wall Street On Friday 03/11/22 What You Missed On Wall Street This Morning 03/11/22 Fly Intel: Pre-market Movers 08:30 Today AirSculpt Technologies - AIRS 09/12/22 AirSculpt Technologies
Hot Stocks	PetroChina to delist shares from NYSE » 06:04 08/12/22 08/12 06:04 08/12/22 06:04 PTR PetroChina $44.91 / +0.78 (+1.77%) PetroChina announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings PTR PetroChina $44.91 / +0.78 (+1.77%) 05/23/22 Citi PetroChina upgraded to Neutral from Sell at Citi 01/04/22 Citi PetroChina downgraded to Sell from Neutral at Citi 11/29/21 JPMorgan PetroChina upgraded to Overweight from Underweight at JPMorgan 10/13/21 JPMorgan PetroChina downgraded to Underweight from Overweight at JPMorgan PTR PetroChina $44.91 / +0.78 (+1.77%) 03/31/22 PetroChina reports 2021 revenue RMB 2.6T, up 35.2% vs. last year
Downgrade	Kahoot downgraded to Sell from Hold at DNB Markets » 06:03 08/12/22 08/12 06:03 08/12/22 06:03 KHOTF Kahoot $2.83 / +0.42 (+17.43%) DNB Markets analyst Frank… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research KHOTF Kahoot $2.83 / +0.42 (+17.43%) 06/24/22 DNB Markets Kahoot downgraded to Hold from Buy at DNB Markets 05/05/22 Nordea Kahoot downgraded to Hold from Buy at Nordea 05/03/22 JPMorgan Kahoot price target lowered to NOK 37 from NOK 40 at JPMorgan 02/28/22 Kepler Cheuvreux Kahoot downgraded to Hold from Buy at Kepler Cheuvreux

Hot Stocks	Rogers Communications, Shaw, Quebecor sign pact for sale of Freedom Mobile » 06:03 08/12/22 08/12 06:03 08/12/22 06:03 RCI Rogers Communications $45.94 / -0.46 (-0.99%) , SJR Shaw Communications $26.98 / +0.02 (+0.07%) Rogers Communications… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly RCI SJR RCI Rogers Communications $45.94 / -0.46 (-0.99%) 07/27/22 Rogers Communications, Shaw extend outside date of proposed merger 07/24/22 Fly Intel: Top five weekend stock stories 07/06/22 Rogers, Shaw report no resolution in mediation with Commissioner of Competition 07/06/22 Rogers, Shaw report no resolution in mediation with Commissioner of Competition SJR Shaw Communications $26.98 / +0.02 (+0.07%) 07/27/22 Rogers Communications, Shaw extend outside date of proposed merger 07/06/22 Rogers, Shaw report no resolution in mediation with Commissioner of Competition 07/06/22 Rogers, Shaw report no resolution in mediation with Commissioner of Competition 06/19/22 Rogers, Shaw to sell Freedom Mobile to Quebecor for C$2.85B RCI SJR RCI Rogers Communications $45.94 / -0.46 (-0.99%) 08/08/22 TD Securities Rogers Communications raised to Action List Buy at TD after recent weakness 08/08/22 TD Securities Rogers Communications upgraded to Action List Buy from Buy at TD Securities 07/29/22 Desjardins Rogers Communications price target lowered to C$79 from C$80 at Desjardins 07/28/22 Canaccord Rogers Communications price target lowered to C$67 from C$68 at Canaccord SJR Shaw Communications $26.98 / +0.02 (+0.07%) 06/28/22 Scotiabank Shaw Communications assumed with a Sector Perform at Scotiabank (yesterday) 06/21/22 Canaccord Shaw Communications upgraded to Buy from Hold at Canaccord 05/18/22 National Bank Shaw upgraded to Outperform from Sector Perform at National Bank 05/06/22 Morgan Stanley Shaw Communications named 'Catalyst Driven Idea' at Morgan Stanley RCI SJR RCI Rogers Communications $45.94 / -0.46 (-0.99%) 07/27/22 Rogers Communications reaffirms 2022 total service revenue view up 6%-8% 07/27/22 Rogers Communications reports Q2 adjusted EPS C$0.86 vs. C$0.76 last year 04/20/22 Rogers Communications raises 2022 revenue view up 6%-8% from up 4%-6% 04/20/22 Rogers Communications reports Q1 adjusted EPS C$0.91 vs. C$0.77 last year SJR Shaw Communications $26.98 / +0.02 (+0.07%) 06/30/22 Shaw Communications reports Q3 EPS C$ 41c vs. C$ 70c last year 04/13/22 Shaw Communications reports Q2 EPS C$0.39 vs. C$0.43 last year RCI SJR RCI Rogers Communications $45.94 / -0.46 (-0.99%) 07/24/22 Rogers to invest C$10B in AI, testing after massive outage, Reuters says 07/10/22 Rogers CEO faces grilling as network woes cast shadow over deal, Bloomberg says 07/08/22 Rogers experiencing broad network failure in Canada, Bloomberg reports 06/03/22 Rogers asks court to dismiss case against Shaw deal, Bloomberg says SJR Shaw Communications $26.98 / +0.02 (+0.07%) 07/10/22 Rogers CEO faces grilling as network woes cast shadow over deal, Bloomberg says 06/24/22 Rogers, Shaw agree to mediation with watchdog over proposed deal, Reuters says 06/23/22 Canada watchdog to ask Rogers to sell Shaw Mobile to clinch deal, Reuters says 06/03/22 Rogers asks court to dismiss case against Shaw deal, Bloomberg says RCI SJR RCI Rogers Communications $45.94 / -0.46 (-0.99%) 07/11/22 What You Missed On Wall Street This Morning 04/20/22 What You Missed On Wall Street On Wednesday 04/20/22 What You Missed On Wall Street This Morning SJR Shaw Communications $26.98 / +0.02 (+0.07%) 07/11/22 What You Missed On Wall Street This Morning 07/01/22 What You Missed On Wall Street On Friday 07/01/22 What You Missed On Wall Street This Morning
Downgrade	Cowen downgrades RealReal, sees 'bumpy path to profitability' » 06:00 08/12/22 08/12 06:00 08/12/22 06:00 REAL RealReal $3.16 / +0.065 (+2.10%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options REAL RealReal $3.16 / +0.065 (+2.10%) 07/27/22 RealReal enters partnership with Beckett Collectibles 06/07/22 RealReal announces Founder Julie Wainwright to stepdown from CEO role 04/29/22 RealReal announces expansion of Sustainability Calculator 03/22/22 RealReal provides long-range financial targets for FY25 REAL RealReal $3.16 / +0.065 (+2.10%) 05:38 Today Cowen RealReal downgraded to Market Perform from Outperform at Cowen 08/10/22 Wells Fargo RealReal price target lowered to $8 from $15 at Wells Fargo 08/10/22 Needham RealReal price target lowered to $6 from $10 at Needham 08/10/22 Wedbush RealReal price target lowered to $5 from $10 at Wedbush REAL RealReal $3.16 / +0.065 (+2.10%) 08/09/22 RealReal sees Q3 revenue $145M-$155M, consensus $164.08M 08/09/22 RealReal sees FY22 revenue $615M-$635M, consensus $652.44M 08/09/22 RealReal reports Q2 adjusted EPS (40c), consensus (43c) 08/09/22 Notable companies reporting after market close REAL RealReal $3.16 / +0.065 (+2.10%) 08/10/22 What You Missed On Wall Street On Wednesday 08/10/22 What You Missed On Wall Street This Morning 08/10/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/09/22 Fly Intel: After-Hours Movers REAL RealReal $3.16 / +0.065 (+2.10%) 08/09/22 RealReal options imply 16.1% move in share price post-earnings 02/23/22 RealReal options imply 16.4% move in share price post-earnings
Downgrade	e.l.f. Beauty downgraded to Market Perform at Cowen on valuation » 05:57 08/12/22 08/12 05:57 08/12/22 05:57 ELF e.l.f. Beauty $36.44 / -0.02 (-0.05%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ELF e.l.f. Beauty $36.44 / -0.02 (-0.05%) 07/05/22 Chairman of e.l.f. Beauty Tarang Amin sells $1.3M in company shares 06/07/22 e.l.f. Beauty CEO: We continue to take market share ELF e.l.f. Beauty $36.44 / -0.02 (-0.05%) 05:38 Today Cowen e.l.f. Beauty downgraded to Market Perform from Outperform at Cowen 08/04/22 Truist e.l.f. Beauty price target raised to $40 from $35 at Truist 07/21/22 JPMorgan e.l.f. Beauty price target raised to $35 from $30 at JPMorgan 05/26/22 Raymond James e.l.f. Beauty price target lowered to $27 from $33 at Raymond James ELF e.l.f. Beauty $36.44 / -0.02 (-0.05%) 08/03/22 e.l.f. Beauty raises FY23 EPSE view to 84c-87c from 78c-81c 08/03/22 e.l.f. Beauty reports Q1 EPS 39c, consensus 23c 05/25/22 e.l.f. Beauty sees FY23 adjusted EPS 78c-81c, consensus 84c 05/25/22 e.l.f. Beauty reports Q4 adjusted EPS 13c, consensus 6c ELF e.l.f. Beauty $36.44 / -0.02 (-0.05%) 07/11/22 Fly Insider: Karuna Therapeutics, HP among weeks notable insider trades 05/25/22 Fly Intel: After-Hours Movers 04/06/22 What You Missed On Wall Street On Wednesday 04/06/22 What You Missed On Wall Street This Morning 11/02/22 e.l.f. Beauty - ELF 08/25/22 E.L.F. BEAUTY 09/13/22 e.l.f. Beauty 09/14/22 e.l.f. Beauty
Upgrade	Alliant Energy upgraded to Buy from Neutral at BofA » 05:56 08/12/22 08/12 05:56 08/12/22 05:56 LNT Alliant Energy $61.67 / -0.295 (-0.48%) BofA analyst Julien… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings LNT Alliant Energy $61.67 / -0.295 (-0.48%) 07/26/22 Mercury Marine, Alliant Energy partner to build solar array 06/23/22 Alliant Energy adjusts timing of Wisconsin-based generation retirement dates 04/05/22 Alliant Energy names two new executive officers LNT Alliant Energy $61.67 / -0.295 (-0.48%) 08/08/22 BofA Alliant Energy price target raised to $62 from $57 at BofA 07/18/22 Barclays Alliant Energy price target lowered to $62 from $68 at Barclays 05/31/22 Argus Alliant Energy price target raised to $70 from $68 at Argus 05/17/22 BofA Alliant Energy upgraded to Neutral from Underperform at BofA LNT Alliant Energy $61.67 / -0.295 (-0.48%) 04/28/22 Alliant Energy still sees 2022 EPS $2.67-$2.81, consensus $2.75 04/28/22 Alliant Energy reports Q1 EPS 77c , consensus 72c 02/17/22 Alliant Energy reports Q4 EPS 35c, consensus 36c
Downgrade	Sally Beauty downgraded to Market Perform from Outperform at Cowen » 05:56 08/12/22 08/12 05:56 08/12/22 05:56 SBH Sally Beauty $15.20 / +0.66 (+4.54%) Cowen analyst Oliver Chen… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly SBH Sally Beauty $15.20 / +0.66 (+4.54%) 06/16/22 Sally Beauty falls -12.7% SBH Sally Beauty $15.20 / +0.66 (+4.54%) 06/29/22 Raymond James Raymond James cuts Sally Beauty to Underperform on exposure low-income consumer 06/29/22 Raymond James Sally Beauty downgraded to Underperform from Market Perform at Raymond James 06/16/22 Morgan Stanley Sally Beauty downgraded to Underweight from Equal Weight at Morgan Stanley 05/06/22 Cowen Sally Beauty price target lowered to $20 from $30 at Cowen SBH Sally Beauty $15.20 / +0.66 (+4.54%) 08/04/22 Sally Beauty lowers FY22 revenue growth view to down 2% from 0%-down 2% 08/04/22 Sally Beauty reports Q3 adjusted EPS 55c, consensus 59c 05/05/22 Sally Beauty lowers FY22 revenue growth view to 0%-down 2% from up 3%-4% 05/05/22 Sally Beauty reports Q2 adjusted EPS 47c, consensus 51c SBH Sally Beauty $15.20 / +0.66 (+4.54%) 06/29/22 What You Missed On Wall Street On Wednesday 06/29/22 What You Missed On Wall Street This Morning 06/29/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/16/22 What You Missed On Wall Street On Thursday
Upgrade	Fresenius SE upgraded to Buy from Hold at HSBC » 05:54 08/12/22 08/12 05:54 08/12/22 05:54 FSNUY Fresenius SE $6.38 / -0.01 (-0.16%) HSBC analyst Sezgi… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research FSNUY Fresenius SE $6.38 / -0.01 (-0.16%) 08/08/22 Credit Suisse Fresenius SE price target lowered to EUR 30 from EUR 38 at Credit Suisse 08/05/22 Deutsche Bank Fresenius SE price target lowered to EUR 28 from EUR 36 at Deutsche Bank 08/05/22 Barclays Fresenius SE price target lowered to EUR 35 from EUR 52.50 at Barclays 07/29/22 DZ Bank Fresenius SE downgraded to Hold from Buy at DZ Bank
Upgrade	UPM-Kymmene upgraded to Buy from Hold at Jefferies » 05:53 08/12/22 08/12 05:53 08/12/22 05:53 UPMMY UPM-Kymmene $34.60 / +0.39 (+1.14%) Jefferies analyst Cole… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research UPMMY UPM-Kymmene $34.60 / +0.39 (+1.14%) 07/22/22 Morgan Stanley UPM-Kymmene price target lowered to EUR 40 from EUR 41 at Morgan Stanley 07/19/22 Credit Suisse UPM-Kymmene price target lowered to EUR 33.80 from EUR 36.80 at Credit Suisse 06/14/22 Danske Bank UPM-Kymmene downgraded to Hold from Buy at Danske Bank 04/25/22 Credit Suisse UPM-Kymmene price target raised to EUR 36.80 from EUR 35.50 at Credit Suisse
Downgrade	Landos Biopharma downgraded to Market Perform from Outperform at Raymond James » 05:51 08/12/22 08/12 05:51 08/12/22 05:51 LABP Landos Biopharma $1.09 / -0.13 (-10.66%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings LABP Landos Biopharma $1.09 / -0.13 (-10.66%) 08/11/22 Landos Biopharma expects cash to fund operations for at least next 12 months 08/03/22 Landos Biopharma announces top-line results from NX-13 Phase 1b trial 06/21/22 Landos Biopharma appoints Gregory Oakes as president, CEO 03/10/22 Landos Biopharma appoints Roger Adsett to board of directors LABP Landos Biopharma $1.09 / -0.13 (-10.66%) 04/12/22 Jefferies Jefferies downgrades Landos Biopharma, slashes target on 'uncertain' pipeline 04/12/22 Jefferies Landos Biopharma downgraded to Hold from Buy at Jefferies 03/25/22 Raymond James Landos Biopharma price target lowered to $9 from $24 at Raymond James 11/18/21 Craig-Hallum Landos Biopharma price target lowered to $29.50 from $45 at Craig-Hallum LABP Landos Biopharma $1.09 / -0.13 (-10.66%) 08/11/22 Landos Biopharma reports Q2 EPS (28c), consensus (33c) 03/24/22 Landos Biopharma reports FY21 EPS ($1.02), consensus (88c)
Initiation	Lexicon initiated with an Overweight at Piper Sandler » 05:50 08/12/22 08/12 05:50 08/12/22 05:50 LXRX Lexicon $2.75 / -0.03 (-1.08%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings LXRX Lexicon $2.75 / -0.03 (-1.08%) 08/02/22 Lexicon reports Q2 EPS (16c), consensus (16c) 07/27/22 Lexicon announces FDA acceptance of NDA for sotagliflozin 06/29/22 Lexicon Pharmaceuticals trading resumes 06/29/22 Lexicon proof-of-concept study of LX9211 achieves primary endpoint LXRX Lexicon $2.75 / -0.03 (-1.08%) 07/01/22 Citi Citi disagrees with Lexicon selloff yesterday, ups target to $20 03/01/22 Citi Lexicon selloff on filing delay a buying opportunity, says Citi 08/30/21 Citi Lexicon price target raised to $20 from $13 at Citi LXRX Lexicon $2.75 / -0.03 (-1.08%) 05/05/22 Lexicon reports Q1 EPS (16c), consensus (16c) 02/28/22 Lexicon reports Q4 EPS (17c), consensus (18c)
Downgrade	Olo downgraded to Neutral from Overweight at Piper Sandler » 05:47 08/12/22 08/12 05:47 08/12/22 05:47 OLO Olo $13.00 / -0.235 (-1.78%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly OLO Olo $13.00 / -0.235 (-1.78%) 05/10/22 Olo appoints Diego Panama as chief revenue officer 04/14/22 Olo, SOCi partner for SOCi integration with Olo API 03/04/22 Olo announces integration with Radar 02/23/22 Olo launches Olo Pay OLO Olo $13.00 / -0.235 (-1.78%) 05:26 Today Stifel Olo downgraded to Hold from Buy at Stifel 07/18/22 Piper Sandler Olo price target lowered to $13 from $14 at Piper Sandler 06/17/22 JPMorgan Olo price target lowered to $21 from $26 at JPMorgan 02/24/22 Truist Olo price target lowered to $25 from $45 at Truist OLO Olo $13.00 / -0.235 (-1.78%) 08/11/22 Olo cuts FY22 revenue view to $183M-$184M, consensus $195.6M 08/11/22 Olo sees Q3 revenue $46.5M-$47.0M, consensus $51.1M 08/11/22 Olo reports Q2 EPS 1c, consensus 0c 05/10/22 Olo sees Q2 revenue $45.5M-$46M, consensus $45.48M OLO Olo $13.00 / -0.235 (-1.78%) 08/11/22 Fly Intel: After-Hours Movers

Periodicals	Samsung heir Jay Y. Lee to receive presidential pardon, Bloomberg reports » 05:46 08/12/22 08/12 05:46 08/12/22 05:46 SSNLF Samsung $57.75 / + (+0.00%) Samsung heir Jay Y. Lee… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly SSNLF Samsung $57.75 / + (+0.00%) 07/28/22 Samsung Display segment Q2 earnings 'solid despite weak seasonality' 07/27/22 Qualcomm, Samsung extend, expand strategic partnership 06/30/22 Samsung begins chip production using 3nm process technology 06/09/22 Microsoft, Samsung partner to bring Xbox Cloud Gaming to Samsung Smart TVs SSNLF Samsung $57.75 / + (+0.00%) 08/11/22 Loop Capital Loop Capital has 'stronger conviction' in Enovix after 'customer milestones' 06/22/22 Loop Capital Samsung initiated with a Buy at Loop Capital 06/13/22 KeyBanc Qualcomm price target raised to $220 from $200 at KeyBanc 06/13/22 UBS Micron price target lowered to $115 from $120 at UBS SSNLF Samsung $57.75 / + (+0.00%) 07/28/22 Samsung reports Q2 EPS KRW 1,613 vs. KRW 1,391 last year 07/06/22 Samsung sees Q2 operating profit KRW14.0T vs. KRW14.6T consensus 04/28/22 Samsung reports Q1 EPS KRW 1,638 vs. KRW 1,044 last year 04/06/22 Samsung sees Q1 operating profit KRW14.1T vs. KRW13.4T consensus SSNLF Samsung $57.75 / + (+0.00%) 08/09/22 Samsung plans $3.3B investment in Vietnam, South China Morning Post reports 08/03/22 Samsung rethinking China exposure amid Chips and Science Act, FT reports 07/21/22 Samsung considering building 11 chipmaking facility, American-Statesman reports 07/18/22 Samsung may hold latest foldable launch event on August 10, Verge says SSNLF Samsung $57.75 / + (+0.00%) 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/06/22 What You Missed This Week in Video Games 06/14/22 What You Missed This Week in Video Games
Downgrade	Six Flags downgraded to Sector Weight at KeyBanc after 'indefensible' Q2 » 05:44 08/12/22 08/12 05:44 08/12/22 05:44 SIX Six Flags $21.12 / -4.685 (-18.16%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly SIX Six Flags $21.12 / -4.685 (-18.16%) 08/11/22 Six Flags falls -22.5% 08/11/22 Six Flags falls -21.5% 08/11/22 Six Flags falls -18.1% 08/11/22 Six Flags reports Q2 attendance 6.7M vs. 8.5M a year ago, down 22% SIX Six Flags $21.12 / -4.685 (-18.16%) 08/11/22 KeyBanc Six Flags downgraded to Sector Weight from Overweight at KeyBanc 07/08/22 Citi Six Flags downgraded to Neutral from Buy at Citi 06/24/22 Stifel Six Flags price target lowered to $35 from $52 at Stifel 06/21/22 B. Riley Six Flags downgraded to Neutral from Buy at B. Riley SIX Six Flags $21.12 / -4.685 (-18.16%) 08/11/22 Six Flags reports Q2 EPS 53c, consensus $1.02 08/10/22 Notable companies reporting before tomorrow's open 08/10/22 Notable companies reporting before tomorrow's open 05/12/22 Six Flags reports Q1 EPS (76c), consensus ($1.04) SIX Six Flags $21.12 / -4.685 (-18.16%) 08/11/22 What You Missed On Wall Street On Thursday 08/11/22 What You Missed On Wall Street This Morning 08/11/22 Fly Intel: Pre-market Movers 07/21/22 Fly Intel: After-Hours Movers
Downgrade	Cowen cuts CS Disco to Market Perform as momentum hits 'big snag' » 05:40 08/12/22 08/12 05:40 08/12/22 05:40 LAW CS Disco $28.96 / +0.39 (+1.37%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly LAW CS Disco $28.96 / +0.39 (+1.37%) 06/06/22 DISCO appoints Tom Furr as CMO 06/01/22 CS Disco falls -10.8% 04/28/22 DISCO appoints Jignasha Amin Grooms as CHRO LAW CS Disco $28.96 / +0.39 (+1.37%) 05:35 Today Cowen CS Disco downgraded to Market Perform from Outperform at Cowen 05:22 Today Jefferies CS Disco downgraded to Hold from Buy at Jefferies 05/23/22 Jefferies CS Disco price target lowered to $35 from $40 at Jefferies 05/13/22 Needham CS Disco price target lowered to $35 from $50 at Needham LAW CS Disco $28.96 / +0.39 (+1.37%) 08/11/22 CS Disco cuts FY22 revenue view to $132M-$136M from $149M-$153M 08/11/22 CS Disco sees Q3 revenue $32M-$34M, consensus $38.29M 08/11/22 CS Disco reports Q2 adjusted (23c), consensus (27c) 05/12/22 CS Disco sees Q2 revenue $32M-$34M, consensus $34.02M 15 Sep LAW CS Disco $28.96 / +0.39 (+1.37%) 08/11/22 Fly Intel: After-Hours Movers 05/12/22 Fly Intel: After-Hours Movers
Downgrade	RealReal downgraded to Market Perform from Outperform at Cowen » 05:38 08/12/22 08/12 05:38 08/12/22 05:38 REAL RealReal $3.16 / +0.065 (+2.10%) Cowen analyst Oliver Chen… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options REAL RealReal $3.16 / +0.065 (+2.10%) 07/27/22 RealReal enters partnership with Beckett Collectibles 06/07/22 RealReal announces Founder Julie Wainwright to stepdown from CEO role 04/29/22 RealReal announces expansion of Sustainability Calculator 03/22/22 RealReal provides long-range financial targets for FY25 REAL RealReal $3.16 / +0.065 (+2.10%) 08/10/22 Wells Fargo RealReal price target lowered to $8 from $15 at Wells Fargo 08/10/22 Needham RealReal price target lowered to $6 from $10 at Needham 08/10/22 Wedbush RealReal price target lowered to $5 from $10 at Wedbush 08/10/22 BofA RealReal double downgraded to Underperform at BofA REAL RealReal $3.16 / +0.065 (+2.10%) 08/09/22 RealReal sees Q3 revenue $145M-$155M, consensus $164.08M 08/09/22 RealReal sees FY22 revenue $615M-$635M, consensus $652.44M 08/09/22 RealReal reports Q2 adjusted EPS (40c), consensus (43c) 08/09/22 Notable companies reporting after market close REAL RealReal $3.16 / +0.065 (+2.10%) 08/10/22 What You Missed On Wall Street On Wednesday 08/10/22 What You Missed On Wall Street This Morning 08/10/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/09/22 Fly Intel: After-Hours Movers REAL RealReal $3.16 / +0.065 (+2.10%) 08/09/22 RealReal options imply 16.1% move in share price post-earnings 02/23/22 RealReal options imply 16.4% move in share price post-earnings
Downgrade	e.l.f. Beauty downgraded to Market Perform from Outperform at Cowen » 05:38 08/12/22 08/12 05:38 08/12/22 05:38 ELF e.l.f. Beauty $36.44 / -0.02 (-0.05%) Cowen analyst Oliver Chen… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ELF e.l.f. Beauty $36.44 / -0.02 (-0.05%) 07/05/22 Chairman of e.l.f. Beauty Tarang Amin sells $1.3M in company shares 06/07/22 e.l.f. Beauty CEO: We continue to take market share ELF e.l.f. Beauty $36.44 / -0.02 (-0.05%) 08/04/22 Truist e.l.f. Beauty price target raised to $40 from $35 at Truist 07/21/22 JPMorgan e.l.f. Beauty price target raised to $35 from $30 at JPMorgan 05/26/22 Raymond James e.l.f. Beauty price target lowered to $27 from $33 at Raymond James 05/26/22 Morgan Stanley e.l.f. Beauty sounded 'very bullish' on earnings call, says Morgan Stanley ELF e.l.f. Beauty $36.44 / -0.02 (-0.05%) 08/03/22 e.l.f. Beauty raises FY23 EPSE view to 84c-87c from 78c-81c 08/03/22 e.l.f. Beauty reports Q1 EPS 39c, consensus 23c 05/25/22 e.l.f. Beauty sees FY23 adjusted EPS 78c-81c, consensus 84c 05/25/22 e.l.f. Beauty reports Q4 adjusted EPS 13c, consensus 6c ELF e.l.f. Beauty $36.44 / -0.02 (-0.05%) 07/11/22 Fly Insider: Karuna Therapeutics, HP among weeks notable insider trades 05/25/22 Fly Intel: After-Hours Movers 04/06/22 What You Missed On Wall Street On Wednesday 04/06/22 What You Missed On Wall Street This Morning 11/02/22 e.l.f. Beauty - ELF 08/25/22 E.L.F. BEAUTY 09/13/22 e.l.f. Beauty 09/14/22 e.l.f. Beauty

Events

Earnings calls, analyst events, roadshows and more

CAAS
Today at 08:00

China Automotive - CAAS Conference Calls
CASI
Today at 08:00

Casi Pharmaceuticals - CASI Conference Calls
GTEC
Today at 08:00

Greenland Technologies - GTEC Conference Calls
VERO
Today at 08:00

Venus Concept - VERO Conference Calls
EVK
Today at 08:00

Ever-Glory - EVK Conference Calls
CMMB
Today at 08:00

Chemomab Therapeutics - CMMB Conference Calls
HUMA
Today at 08:00

Humacyte - HUMA Conference Calls
Today at 08:30

Import Prices M/M: July 2022 Government Event
Today at 08:30

Import Prices Y/Y: July 2022 Government Event
Today at 08:30

Export Prices M/M: July 2022 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	AYTU X AYTU Aytu BioPharma Spot Secondary Managers: Cantor Fitzgerald & Canaccord Priced at: $0.43 21.5M Shares BRBR X BRBR BellRing Brands Spot Secondary Managers: JPMorgan, Barclays, Citi, Goldman Sachs & Morgan Stanley Priced at: $23.50 14.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MDNA X MDNA Medicenna Therapeutics Spot Secondary Managers: Guggenheim, Bloom Burton Securities Priced at: $1.50 13.333M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NUZE X NUZE NuZee Spot Secondary Managers: Maxim Priced at: $0.82 4.2M Shares PFLT X PFLT PennantPark Floating Rate Spot Secondary Managers: Morgan Stanley, Goldman Sachs, JPMorgan, Keefe Bruyette, RBC Capital & Truist Priced at: $12.40 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan, Jefferies Priced at: $215.00 3.49M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MIRM X MIRM Mirum Pharmaceuticals Spot Secondary Managers: JPMorgan, SVB Securities & Evercore ISI, Raymond James Priced at: $23.00 3.48M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TDW X TDW Tidewater Spot Secondary Managers: Morgan Stanley Priced at: $17.85 3.52M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	ATNX X ATNX Athenex Secondary Managers: SVB Securities Priced at: $.75 35.3M Shares CINC X CINC CinCor Pharma Secondary Managers: Goldman Sachs, Morgan Stanley, Jefferies & Piper Sandler Priced at: $30.00 7.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EVTC X EVTC Evertec Secondary Managers: JPMorgan Priced at: $32.00 6.26M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LXU X LXU LSB Industries Secondary Managers: Goldman Sachs & UBS, Deutsche Bank, Jefferies, Piper Sandler, RBC Capital, BNP Paribas, Stifel Priced at: $13.00 13.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SOVO X SOVO Sovos Brands Secondary Managers: JPMorgan & Goldman Sachs, BofA, Credit Suisse, Barclays, UBS, Cowen, Piper Sandler, Stifel, William Blair, Telsey Advisory, Drexel Hamilton, Loop Capital Priced at: $14.00 8.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRNA X VRNA Verona Pharma Secondary Managers: Jefferies, Piper Sandler & Truist Priced at: $10.50 12.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNL X BNL Broadstone Net Lease Spot Secondary Managers: Goldman Sachs, BMO Capital, JPMorgan & Truist Priced at: $21.35 13M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KIDS X KIDS OrthoPediatrics Spot Secondary Managers: Piper Sandler & Stifel Priced at: $55.00 750K Shares MAIN X MAIN Main Street Spot Secondary Managers: RBC Capital, UBS & Wells Fargo Priced at: $42.85 1.17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	FRZA X FRZA Forza X1 IPO Managers: ThinkEquity Priced at: $5.00 3M Shares REBN X REBN Reborn Coffee IPO Managers: EF Hutton Priced at: $5.00 1.44M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TGL X TGL Treasure Global IPO Managers: EF Hutton Priced at: $4.00 2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PTLO X PTLO Portillo's Secondary Managers: Jefferies & Morgan Stanley, BofA, Piper Sandler Priced at: $23.75 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	BIAF X BIAF Bioaffinity Technologies IPO Managers: WallachBeth $6.00-6.25 1.285M Shares
Wed	No deals
Thurs	CERE X CERE Cerevel Therapeutics Secondary Managers: Morgan Stanley, Goldman Sachs, Jefferies & Evercore ISI, Loop Capital, Seibert Williams $41.42 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RANI X RANI Rani Therapeutics Secondary Managers: BofA, Cantor Fitzgerald & UBS, BTIG, H.C. Wainwright $11.11 CERT X CERT Certara Spot Secondary Managers: Morgan Stanley $17.75-18.50 7M Shares INSP X INSP Inspire Medical Spot Secondary Managers: Goldman Sachs $215.00-222.46 1M Shares
Fri	No deals

View All Syndicate Announcements »

Real Good Food launches Real Good Foods Perks Program

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access